Company

Mendus AB

Biotechnology Research Stockholm, Stockholms Län, Se 34 employees IMMU

Employees: 34
Contacts: 2
Emails: 2
Phones: 1

immunicum.se LinkedIn

Mendus AB Overview

Headquarters: Stockholm, Stockholms Län, Se
Website: immunicum.se
Industry: Biotechnology Research
Employees: 34
Stock Symbol: IMMU
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

in allogeneic dendritic cell biology to develop an advanced clinical pipeline of novel

About Mendus AB

Mendus is dedicated to changing the course of cancer treatment by addressing tumor recurrence and improving survival outcomes for cancer patients, while preserving quality of life. We are leveraging our unparalleled expertise in allogeneic dendritic cell biology to develop an advanced clinical pipeline of novel, off-the-shelf, cell-based immunotherapies which combine clinical efficacy with a benign safety profile. Based in Sweden and The Netherlands, Mendus is publicly traded on the Nasdaq Stockholm under the ticker IMMU.ST.

Mendus AB Contact Details

People in AeroLeads: 4
With contact data: 2
Email contacts: 2; 50.0% coverage
Phone contacts: 1; 25.0% coverage

Mendus AB Org Chart

Sample employees and titles

Name	Title	Location	Contact
Annelies Legters, Msc		The Randstad, Netherlands	Email Phone
Jeroen Rovers	Chief Medical Officer at Mendus	The Hague, South Holland, Netherlands	Email
Leopold Bertea	Senior Operations Leader		View
Hester Van Zeeburg	Immunology - Biomarkers - Clinical		View